A syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T-cell lymphoma

Blood

Volumn 91, Issue 6, 1998, Pages 2085-2091

  Kanegane, Hirokazu ^b   Bhatia, Kishor ^b   Gutierrez, Marina ^b   Kaneda, Hisashi ^b   Wada, Taizo ^b   Yachie, Akihiro ^b   Seki, Hidetoshi ^b   Arai, Takashi ^b   Kagimoto, Sei Ichi ^b   Okazaki, Minoru ^b   Oh ishi, Tsutomu ^b   Moghaddam, Amir ^b   Wang, Fred ^b   Tosato, Giovanna ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; VIRUS ANTIBODY;

ANTIBODY TITER; ARTICLE; CASE REPORT; CHILD; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; GENETIC VARIABILITY; HELPER CELL; HUMAN; HUMAN CELL; INFECTIOUS MONONUCLEOSIS; MALE; PRIORITY JOURNAL; T CELL LYMPHOMA; VIRUS CARCINOGENESIS; VIRUS GENE; VIRUS INFECTION;

EID: 0032521451     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.6.2085.2085_2085_2091     Document Type: Article

References (40)

1. Straus SE, Cohen JI, Tosato G, Meier J: Epstein-Barr virus infection: biology, pathogenesis, and management. Ann Intern Med 118:45, 1993
2. Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, Johnson A, Rickinson AB: Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 69:1051, 1988
3. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS: Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337:320, 1991
4. Weiss LS, Chen YY, Liu XF, Shibata D: Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chin reaction study. Am J Pathol 139:1259, 1991
5. McClain KL, Leach CT, Jensen HB, Joshi VJ, Pollock BH, Parmley RT, DiCarlo FJ, Chadwick EG, and Murphy SB: Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS. N Engl J Med 332:12, 1995
6. Lee, ES, Locker J, Nalesnik M, Reyes J, Jaffe R, Alashari M, Nour B, Tzakis A, Dickman PS: The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med 332:19, 1995
7. Shibata D, Tokunaga M, Uemura Y, Sato E, Tanaka S, Weiss LM: Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol 139:469, 1991
8. Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, Tanaka S, Sato E, Osato T: Gastric carcinoma: Monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 91:9131, 1994
9. Mori M, Kurozumi H, Akagi K, Tanaka Y, Imai S, Osato T: Monoclonal proliferation of T cells containing Epstein-Barr virus in fatal mononucleosis. N Engl J Med 327:58, 1992
10. Kikuta H, Taguchi Y, Tomizawa K, Kojima K, Kawamura N, Ishizaka A, Sakiyama Y, Matsumoto S, Imai S, Kinoshita T, Koizumi S, Osato T, Kobayashi I, Hamada I, Hirai K: Nature 333:455, 1988
11. Ishihara S, Tawa A, Yumura-Yagi K, Murata M, Hara J, Yabuuchi H, Hirai K, Kawa-Ha K: Clonal T-cell lymphoproliferation containing Epstein-Barr (EB) virus DNA in a patient with chronic active EB virus infection. Jpn J Cancer Res 80:99, 1989
12. Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Mizuno F, Osato T: Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 335:128, 1990
13. Jaffe ES: Nasal and nasal T/NK cell lymphoma: A unique form of lymphoma associated with the Epstein-Barr virus. Histopathology 27:581, 1995
14. Jones JF, Shurin S, Abramowsky C, Tubbs RR, Sciotto CG, Wahl R, Sands J, Gottman D, Katz BZ, Sklar J: T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infection. N Engl J Med 318:733, 1988
15. Bonagura VR, Katz BZ, Edwards BL, Valacer DJ, Nisen P, Gloster E, Mir R, Lanzkowsky P: Severe chronic EBV infection associated with specific EBV immunodeficiency and an EBNA+ T-cell lymphoma containing linear, EBV DNA. Clin Immunol Immunopathol 57:32, 1990
16. Su IJ, Hsieh HC, Lin KH, Uen WC, Kao CL, Chen CJ, Cheng AL, Kadin ME, Chen JY: Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: A clinicopathologic and molecular analysis. Blood 77:799, 1991
17. Zhou XG, Hamilton-Dutoit SJ, Van QH, Pallesen G: High frequency of Epstein-Barr virus in Chinese peripheral T-cell lymphoma. Histopathology 24:115, 1994
18. Stevenson M., Volsky B, Hedenskog M, Volsky DJ: Immortalization of human T lymphocytes after transfection of Epstein-Barr virus DNA. Science 233:980, 1986
19. Watry D, Hedrick JA, Siervo S, Rhodes G, Lamberti JJ, Lambris JD, Tsoukas CD: Infection of human thymocytes by Epstein-Barr virus. J Exp Med 173:971, 1991
20. Kawa-Ha K, Ishihara S, Ninomiya T, Yumura-Yagi K, J Hara J, Murayama F, Tawa A, Hirai K: CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr virus DNA. J Clin Invest 84:51, 1989
21. Fukunaga Y, Asano T, Takehana J, Ambo K, Matsuoka K, Yamamoto M: CD3-negative lymphoproliferative disease of granular lymphocytes in a girl with an unusual pattern of anti-Epstein-Barr virus antibodies. Eur J Pediatr 153:894, 1994
22. Kanegane H, Wada T, Nunogami K, Seki H, Taniguchi N, Tosato G: Chronic persistent Epstein-Barr virus infection of natural killer cells and B cells associated with granular lymphocytes expansion. Br J Haematol 95:116, 1996
23. Imai S, Sugiura M, Oikawa O, Koizumi S, Hirao M, Kimura H, Hayashibara H, Terai N, Tsutsumi H, Oda T, Chiba S, Osato T: Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection. Blood 87:1446, 1996
24. Hironaka T, Nagasaki M, Morikawa S, Hirai K: Detection of Epstein-Barr virus transcripts in chemically or immunologically-activated cells and in a null-cell line (HLN-STL-C) by in situ hybridization with alkaline phosphatase-linked oligonucleotide probes. J Virol Method 44:141, 1993
25. Raab-Traub N, Flynn K: The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883, 1986
26. Kunimoto M, Tamura S, Tabata T, Yoshie O: One-step typing of Epstein-Barr virus by polymerase chain reaction: Predominance of type 1 in Japan. J Gen Virol 73:455, 1992
27. Khanim F, Yao QY, Niedobitek G, Sihota S, Rickinson AB, Young LS: Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 88:3491, 1996
28. Bhatia K, Raj A, Guitierrez MI, Judde JG, Spangler G, Venkatesh H, Magrath IT: Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas. Oncogene 13:177, 1996
29. Kanegane H, Wang F, Tosato G: Virus-cell interaction in a natural killer-like cell line from a patient with lymphoblastic lymphoma. Blood 88:4667, 1996
30. Zimbe U, Adldinger HK, Lenoir GM, Vuillaume M, Knebel-Doeberitz MV, Lauz G, Desgranges C, Wittmann P, Freese UK, Schneider U, Bornkamm GW: Geographic prevalence of two types of Epstein-Barr virus. Virology 154: 56, 1986
31. Miller WE, Edwards RH, Walling DM, Raab-Traub N: Sequence variation in the Epstein-Barr virus latent membrane protein 1. J Gen Virol 75: 2729, 1994
32. Wang D, Liebowitz D, Kieff E: An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831, 1986
33. Koizumi S, Zhang XK, Imai S, Sugiura M, Usui N, Osato T: Infection of the HTLV-I-harbouring T-lymphoblastoid line MT-2 by Epstein-Barr virus. Virology 188:859, 1992
34. Sinha SK, Todd SC, Hedrick JA, Speiser CL, Lamris JD, Tsoukas CD: Characterization of the EBV/C3d receptor on the human Jurkat T cell line: Evidence for a novel transcript. J Immunol 150:5311, 1993
35. Yoshiyama H, Shimizu N, Takada K: Persistent Epstein-Barr virus infection in a human T-cell line: Unique program of latent virus expression. EMBO J 14:3706, 1995
36. Kelleher CA, Paterson RK, Dreyfus DH, Streib JE, Wu Xu J, Takase K, Jones JF, Gelfand EW: Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes. Simultaneous early expression of BZLF-1 and its repressor RAZ. Virology 208:685, 1995
37. Paterson RK, Kelleher C, Amankonah TD, Tstreib JE, Wu Xu J, Jones JF, Gelfand EW: Model of Epstein-Barr virus infection of human thymocytes: Expression of viral genome and impact on cellular receptor expression in the T-lymphoblastic cell line, HPB-ALL. Blood 85:456, 1995
38. Yoneda N, Tatsumi E, Kawanishi M, Teshigawara K, Masuda S, Yamamura Y, Inui A, Yoshio G, Oimomi M, Baba S, Yamaguchi N: Detection of Epstein-Barr virus genome in benign polyclonal proliferative T cells of a young male patient. Blood 76:172, 1990
39. Anagnostopoulos I, Hummel M, Kreschel C, Stein H: Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: Implications for the interindividual infection route of Epstein-Barr virus. Blood 85:744, 1995
40. Masucci MG, and Ernberg I: Epstein-Barr virus: Adaptation to a life within the immune system. Trends Microbiol 2:125, 1994